Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
1.660
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
1.650
-0.010 (-0.60%)
After-hours: Nov 13, 2026, 7:30 PM EST

Xenetic Biosciences Revenue

Xenetic Biosciences had revenue of $725.26K in the quarter ending September 30, 2026, a decrease of -29.38%. This brings the company's total for the last twelve months to $2.96M, up 3.50% year-over-year. In the year 2025, Xenetic Biosciences had annual revenue of $2.98M with 19.04% growth. That makes Xenetic Biosciences the 41,240th largest company in the world by revenue and 5,533rd in the United States.

Revenue (ttm)
$2.96M
Revenue Growth
+3.50%
P/S Ratio
1.37
Revenue / Employee
$1,479,539
Employees
2
Market Cap
3.89M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.98M476.13K19.04%
Dec 31, 20242.50M-39.70K-1.56%
Dec 31, 20232.54M833.06K48.80%
Dec 31, 20221.71M546.23K47.06%
Dec 31, 20211.16M723.75K165.64%
Dec 31, 2020436.94K419.88K2,460.31%
Dec 31, 201917.07K--
Dec 31, 2018---
Dec 31, 20177.59M4.59M152.83%
Dec 31, 20163.00M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 20131.00M706.40K240.60%
Dec 31, 2012293.60K--
Aug 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.